Home
gpo.gov
govinfo.gov

e-CFR Navigation Aids

Browse

Simple Search

Advanced Search

 — Boolean

 — Proximity

 

Search History

Search Tips

Corrections

Latest Updates

User Info

FAQs

Agency List

Incorporation By Reference

eCFR logo

Related Resources

Electronic Code of Federal Regulations

We invite you to try out our new beta eCFR site at https://ecfr.federalregister.gov. We have made big changes to make the eCFR easier to use. Be sure to leave feedback using the Help button on the bottom right of each page!

e-CFR data is current as of October 22, 2020

Title 38Chapter IPart 4Subpart B → §4.116


Title 38: Pensions, Bonuses, and Veterans' Relief
PART 4—SCHEDULE FOR RATING DISABILITIES
Subpart B—Disability Ratings


§4.116   Schedule of ratings—gynecological conditions and disorders of the breast.

   Rating
Note 1: Natural menopause, primary amenorrhea, and pregnancy and childbirth are not disabilities for rating purposes. Chronic residuals of medical or surgical complications of pregnancy may be disabilities for rating purposes.
Note 2: When evaluating any claim involving loss or loss of use of one or more creative organs or anatomical loss of one or both breasts, refer to §3.350 of this chapter to determine whether the veteran may be entitled to special monthly compensation. Footnotes in the schedule indicate conditions which potentially establish entitlement to special monthly compensation; however, almost any condition in this section might, under certain circumstances, establish entitlement to special monthly compensation.
7610   Vulva or clitoris, disease or injury of (including vulvovaginitis)
7611   Vagina, disease or injury of.
7612   Cervix, disease or injury of.
7613   Uterus, disease, injury, or adhesions of.
7614   Fallopian tube, disease, injury, or adhesions of (including pelvic inflammatory disease (PID)).
7615   Ovary, disease, injury, or adhesions of.
General Rating Formula for Disease, Injury, or Adhesions of Female Reproductive Organs (diagnostic codes 7610 through 7615):
Symptoms not controlled by continuous treatment30
Symptoms that require continuous treatment10
Symptoms that do not require continuous treatment0
Note: For the purpose of VA disability evaluation, a disease, injury, or adhesions of the ovaries resulting in ovarian dysfunction affecting the menstrual cycle, such as dysmenorrhea and secondary amenorrhea, shall be rated under diagnostic code 7615   
7617   Uterus and both ovaries, removal of, complete:
For three months after removal1100
Thereafter150
7618   Uterus, removal of, including corpus:
For three months after removal1100
Thereafter130
7619   Ovary, removal of:
For three months after removal1100
Thereafter:
Complete removal of both ovaries130
Removal of one with or without partial removal of the other10
Note: In cases of the removal of one ovary as the result of a service-connected injury or disease, with the absence or nonfunctioning of a second ovary unrelated to service, an evaluation of 30 percent will be assigned for the service-connected ovarian loss
7620   Ovaries, atrophy of both, complete120
7621   Complete or incomplete pelvic organ prolapse due to injury, disease, or surgical complications of pregnancy10
Note: Pelvic organ prolapse occurs when a pelvic organ such as bladder, urethra, uterus, vagina, small bowel, or rectum drops (prolapse) from its normal place in the abdomen. Conditions associated with pelvic organ prolapse include: uterine or vaginal vault prolapse, cystocele, urethrocele, rectocele, enterocele, or any combination thereof. Evaluate pelvic organ prolapse under DC 7621. Evaluate separately any genitourinary, digestive, or skin symptoms under the appropriate diagnostic code(s) and combine all evaluations with the 10 percent evaluation under DC 7621
7624   Fistula, rectovaginal:
Vaginal fecal leakage at least once a day requiring wearing of pad100
Vaginal fecal leakage four or more times per week, but less than daily, requiring wearing of pad60
Vaginal fecal leakage one to three times per week requiring wearing of pad30
Vaginal fecal leakage less than once a week10
Without leakage0
7625   Fistula, urethrovaginal:
Multiple urethrovaginal fistulae100
Requiring the use of an appliance or the wearing of absorbent materials which must be changed more than four times per day60
Requiring the wearing of absorbent materials which must be changed two to four times per day40
Requiring the wearing of absorbent materials which must be changed less than two times per day20
7626   Breast, surgery of:
Following radical mastectomy:
Both180
One150
Following modified radical mastectomy:
Both160
One140
Following simple mastectomy or wide local excision with significant alteration of size or form:
Both150
One130
Following wide local excision without significant alteration of size or form:
Both or one0
Note: For VA purposes:
(1) Radical mastectomy means removal of the entire breast, underlying pectoral muscles, and regional lymph nodes up to the coracoclavicular ligament.
(2) Modified radical mastectomy means removal of the entire breast and axillary lymph nodes (in continuity with the breast). Pectoral muscles are left intact.
(3) Simple (or total) mastectomy means removal of all of the breast tissue, nipple, and a small portion of the overlying skin, but lymph nodes and muscles are left intact.
(4) Wide local excision (including partial mastectomy, lumpectomy, tylectomy, segmentectomy, and quadrantectomy) means removal of a portion of the breast tissue.
7627   Malignant neoplasms of gynecological system100
Note: A rating of 100 percent shall continue beyond the cessation of any surgical, radiation, antineoplastic chemotherapy or other therapeutic procedures. Six months after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination. Any change in evaluation based upon that or any subsequent examination shall be subject to the provisions of §3.105(e) of this chapter. Rate chronic residuals to include scars, lymphedema, disfigurement, and/or other impairment of function under the appropriate diagnostic code(s) within the appropriate body system
7628   Benign neoplasms of gynecological system. Rate chronic residuals to include scars, lymphedema, disfigurement, and/or other impairment of function under the appropriate diagnostic code(s) within the appropriate body system
7629   Endometriosis:
Lesions involving bowel or bladder confirmed by laparoscopy, pelvic pain or heavy or irregular bleeding not controlled by treatment, and bowel or bladder symptoms50
Pelvic pain or heavy or irregular bleeding not controlled by treatment30
Pelvic pain or heavy or irregular bleeding requiring continuous treatment for control10
Note: Diagnosis of endometriosis must be substantiated by laparoscopy.
7630   Malignant neoplasms of the breast100
Note: A rating of 100 percent shall continue beyond the cessation of any surgical, radiation, antineoplastic chemotherapy or other therapeutic procedure. Six months after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination. Any change in evaluation based upon that or any subsequent examination shall be subject to the provisions of §3.105(e) of this chapter. Rate chronic residuals according to impairment of function due to scars, lymphedema, or disfigurement (e.g., limitation of arm, shoulder, and wrist motion, or loss of grip strength, or loss of sensation, or residuals from harvesting of muscles for reconstructive purposes), and/or under diagnostic code 7626
7631   Benign neoplasms of the breast and other injuries of the breast. Rate chronic residuals according to impairment of function due to scars, lymphedema, or disfigurement (e.g., limitation of arm, shoulder, and wrist motion, or loss of grip strength, or loss of sensation, or residuals from harvesting of muscles for reconstructive purposes), and/or under diagnostic code 7626
7632   Female sexual arousal disorder (FSAD)10

1Review for entitlement to special monthly compensation under §3.350 of this chapter.

(Authority: 38 U.S.C. 1155)

[60 FR 19855, Apr. 21, 1995, as amended at 67 FR 6874, Feb. 14, 2002; 67 FR 37695, May 30, 2002; 83 FR 15071, Apr. 9, 2018]

Need assistance?